poisar

Stocks · News reference

MetroTrade Partners with Payward Services Derivatives to Launch New Futures Brokerage

Fiscal.ai

Retail futures broker MetroTrade has launched a rebuilt trading platform and brokerage service in partnership with Payward Services Derivatives, providing expanded access to CME Group futures products.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. The Motley FoolErin Kennedy

    CME vs. Upstart: Which Financial Stock Is a Better Buy for 2027?

    The article compares CME Group and Upstart as investment options for 2027. CME Group is a mature, profitable derivatives marketplace with $4 billion in net income, low leverage, and strong free cash flow of $4.2 billion, trading at a lower forward P/E of 25.8. Upstart is a high-growth AI-powered lending platform with 64% revenue growth but carries higher leverage (debt-to-equity of 2.3), negative free cash flow of $166.1 million, and a higher forward P/E of 48.6. The author recommends CME Group for investors seeking stability and dividends, while Upstart appeals to growth-focused investors.

  2. The Motley FoolSean Williams

    The Latest Federal Reserve Interest Rate Forecast Points to 4 Hikes by mid-September -- and That's Terrible News for Wall Street

    Fed Chair Kevin Warsh's hardline stance on inflation could lead to at least 100 basis points of interest rate hikes by mid-September 2027, according to CME FedWatch forecasts. Rising rates driven by Trump's tariffs, energy disruptions, and AI infrastructure costs could slow the AI data center build-out and trigger valuation re-ratings in an already historically expensive stock market.

  3. The Motley FoolDavid Jagielski, Cpa

    Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500

    The article predicts that the Federal Reserve's interest rate decision on December 9, 2026 will be a turning point for the S&P 500. With a 94% probability of a 25 basis point rate hike and a 6% chance of a 50 basis point increase, the author expects the announcement to trigger significant market selling, potentially pushing the S&P 500 into correction or bear market territory by year-end. Recent inflation data and tech sector weakness have already pressured markets.

  4. The Motley FoolErin Kennedy

    CME vs. Morningstar: Which Financial Stock Is a Better Buy for 2027?

    The article compares CME Group and Morningstar as investment options for 2027. CME Group operates the global derivatives market with exceptional 63% net margins and pays a 1.6% dividend, but trades at a premium valuation (P/E 26.07). Morningstar offers investment research and data with lower valuation multiples (P/E 21.53) but lower profitability (17% net margin). Over the past decade, Morningstar outperformed CME by 60 percentage points, though both underperformed the S&P 500. The author recommends CME for 2027 but suggests considering S&P 500 ETFs as an alternative.

  5. The Motley FoolSean Williams

    There's Now a 100% Chance of a Fed Rate Hike in December -- but That's Not the Worst News for Wall Street

    The Federal Reserve is now expected to raise interest rates on December 9, 2026 with 100% probability according to CME Group's FedWatch Tool. More concerning for markets is the possibility of a 50-basis-point hike rather than 25 basis points, as Fed Governor Christopher Waller suggested more aggressive action may be needed if inflation remains elevated. This aggressive rate-hiking cycle poses significant risks to the stock market, particularly tech stocks that have driven recent gains and rely on debt financing for AI infrastructure buildout.